These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9825135)

  • 1. [Prophylaxis of pancreatogenic disturbances by infusion of monomer-electrolyte solutions combined with dalargin].
    Koval'skaia KS; Emel'ianov SI
    Biull Eksp Biol Med; 1998 Oct; 126(10):401-4. PubMed ID: 9825135
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enteral correction of homeostasis in acute pancreatitis].
    Penin VA; Emel'ianov SI; Rybakov GS; Koval'skaia KS; Strusov VV; Zhuravleva GM
    Khirurgiia (Mosk); 1996; (2):8-11. PubMed ID: 8754889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
    Pobuts'kyĭ OO
    Klin Khir; 2002 Jan; (1):26-9. PubMed ID: 11944292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphofunctional changes in the pancreas in response to dalargin under normal conditions and in experimental pancreatitis].
    Kurzanov AN; Titova GP; Vinogradov VA; Aleĭnik VA; Gerasimov NF
    Biull Eksp Biol Med; 1988 Apr; 105(4):445-7. PubMed ID: 3359026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of regulator peptides on pancreatic endocrine function in experimental acute pancreatitis].
    Tsvirkun VV; Grigorevskiĭ VP; Botsmanov KV; Bocharova VS
    Biull Eksp Biol Med; 1989 Dec; 108(12):748-51. PubMed ID: 2576773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mechanisms of antioxidant action of dalargin on the liver in experimental cholestasis].
    Korotkina RN; Fomchenkov EP; Andreev VI; Smirnova VI; Karelin AA
    Biull Eksp Biol Med; 1992 Jan; 113(1):38-40. PubMed ID: 1391860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dalargin in the prevention of acute postoperative pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Pomelov VS; Shloznikov BM; Karelin AA
    Klin Khir (1962); 1989; (11):9-12. PubMed ID: 2640568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enteral infusions of monomer-electrolyte solutions in massive blood loss].
    Gal'perin IuM; Koval'skaia KS; Katkovskiĭ GB
    Khirurgiia (Mosk); 1988 Apr; (4):75-80. PubMed ID: 3398420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanisms of enteral correction of posthemorrhagic hypovolemia].
    Koval'skaia KS
    Vestn Akad Med Nauk SSSR; 1991; (9):42-6. PubMed ID: 1750244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dalargin--the first enkephalin analog, used in gastroenterology].
    Vinogradov VA; Polonskiĭ VM
    Ter Arkh; 1988; 60(8):147-53. PubMed ID: 3067406
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the synthetic leu-enkephalin analog dalargin on liver metabolism and blood supply in acute blood loss in rats].
    Zoloev GK; Kovalenko NIa; Matsievskiĭ DD
    Patol Fiziol Eksp Ter; 1988; (3):48-52. PubMed ID: 3174252
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the effect of kontrikal, 5-fluorouracil and the new Soviet peptide preparation dalargin on the course of experimental pancreonecrosis].
    Georgadze AK; Permiakov NK; Penin VA; Titov MI; Titova GP
    Farmakol Toksikol; 1986; 49(6):66-70. PubMed ID: 2434356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of an analog of endogenous opioids, dalargin, on the structure and function of the exocrine tissue of the pancreas in experimental acute pancreatitis].
    Georgadze AK; Permiakov NK; Vinogradov VA; Penin VA; Titova GP
    Farmakol Toksikol; 1985; 48(5):101-4. PubMed ID: 2416590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of dalargin on some parameters of peroxidation of liver lipids in experimental animals].
    Shloznikov BM; Korotkina RN; Babkina NV; Karelin AA; Fomchenkov EP
    Biull Eksp Biol Med; 1990 Dec; 110(12):609-10. PubMed ID: 2083360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of dalargin on the hemodynamics in acute myocardial infarct complicated by clinical death].
    Lisachenko GV; Slepushkin VD; Zoloev GK
    Anesteziol Reanimatol; 1992; (4):57-9. PubMed ID: 1485679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac output and regional blood flows during intravenous infusion of an amino acid mixture in dogs. IV.
    Hallberg D; Andreen M; Odensjö G; Soda M
    Acta Chir Scand; 1974; 140(6):441-4. PubMed ID: 4428919
    [No Abstract]   [Full Text] [Related]  

  • 18. [The reinfusion of blood and the administration of dalargin in experimental hemorrhagic shock].
    Sherman DM; Trach VM
    Klin Khir (1962); 1994; (9):38-41. PubMed ID: 7602944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Skomarovskiĭ ATs; Zemskov VS; Skomarovskiĭ AA
    Klin Khir; 1996; (8):13-4. PubMed ID: 9064131
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of acute hemorrhage during catecholamine infusion in splenectomized dogs.
    Buckley NM; Frank MH; Zeig NJ; Bass BG; Macy J
    Am J Physiol; 1967 Mar; 212(3):579-88. PubMed ID: 5335940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.